KASTx Life Science Fund I announces the first closing of its inaugural fund with a target size of CA$5M. Focusing on pre-seed and seed life sciences companies, the fund aims to support commercially scalable ventures sharing a common goal to improve societal outcomes in health and technology.
“Lawrence believes not only in thinking outside the box but that there is no box to constrain our innovations at all. As a neuromuscular neurologist, he is working to drive better health outcomes. Challenges in healthcare are global – which means the impact of new advancements can be far-reaching. Learn Read more…
“Episode 4 of the Now Innovating podcast at UCalgary features Dr. Korngut and his research focused on accelerating new medical therapies in hopes of shortening the temporal gap between research and development. His start-up Lumiio specializes in real-world data collection services that help patient organizations, academic research groups, and pharmaceutical Read more…
A new model is making waves that is changing the landscape for how life sciences companies can translate their technologies into use for the benefit of the public. The portfolio model presents a new way to diversify investment opportunities as well as the skills brought in to help work towards the success of biotech research.